Jose O Maximo1, Eric A Nelson2, William P Armstrong1, Nina V Kraguljac1, Adrienne C Lahti3. 1. Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama. 2. Department of Psychology, University of Alabama at Birmingham, Birmingham, Alabama. 3. Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama. Electronic address: alahti@uabmc.edu.
Abstract
BACKGROUND: In the United States, the average duration of untreated psychosis (DUP) is 21 months, and it remains unknown how longer DUP may affect brain functioning in antipsychotic-naïve patients with first-episode psychosis. The objective was to determine the effects of DUP on functional connectivity and brain morphology measured with resting-state functional and structural magnetic resonance imaging. METHODS: Medication-naïve patients with first-episode psychosis were referred from various clinical settings. After accounting for exclusion criteria, attrition, and data quality, final analyses included 55 patients (35 male and 20 female; mean age, 24.18 years). Patients with first-episode psychosis were subjected to a 16-week trial of risperidone, a commonly used antipsychotic drug. Treatment response was calculated as change in the psychosis subscale of the Brief Psychiatric Rating Scale between baseline and 16 weeks. Resting-state functional connectivity magnetic resonance imaging and brain morphology (surface area and cortical thickness) were assessed. RESULTS: Longer DUP was associated with worse treatment response and reduced functional connectivity-more specifically in the default, salience, and executive networks. Moreover, longer DUP was associated with reduced surface area in the salience and executive networks and with increased cortical thickness in the default mode and salience networks. When the functional connectivity of the default mode network was added as a mediator, the relationship between DUP and treatment response was no longer significant. CONCLUSIONS: These data suggest that several neurobiological alterations in the form of reduced functional connectivity and surface area and increased cortical thickness underpin the effect of prolonged DUP.
BACKGROUND: In the United States, the average duration of untreated psychosis (DUP) is 21 months, and it remains unknown how longer DUP may affect brain functioning in antipsychotic-naïve patients with first-episode psychosis. The objective was to determine the effects of DUP on functional connectivity and brain morphology measured with resting-state functional and structural magnetic resonance imaging. METHODS: Medication-naïve patients with first-episode psychosis were referred from various clinical settings. After accounting for exclusion criteria, attrition, and data quality, final analyses included 55 patients (35 male and 20 female; mean age, 24.18 years). Patients with first-episode psychosis were subjected to a 16-week trial of risperidone, a commonly used antipsychotic drug. Treatment response was calculated as change in the psychosis subscale of the Brief Psychiatric Rating Scale between baseline and 16 weeks. Resting-state functional connectivity magnetic resonance imaging and brain morphology (surface area and cortical thickness) were assessed. RESULTS: Longer DUP was associated with worse treatment response and reduced functional connectivity-more specifically in the default, salience, and executive networks. Moreover, longer DUP was associated with reduced surface area in the salience and executive networks and with increased cortical thickness in the default mode and salience networks. When the functional connectivity of the default mode network was added as a mediator, the relationship between DUP and treatment response was no longer significant. CONCLUSIONS: These data suggest that several neurobiological alterations in the form of reduced functional connectivity and surface area and increased cortical thickness underpin the effect of prolonged DUP.
Authors: Jonathan D Power; Anish Mitra; Timothy O Laumann; Abraham Z Snyder; Bradley L Schlaggar; Steven E Petersen Journal: Neuroimage Date: 2013-08-29 Impact factor: 6.556
Authors: Sun Woo Lee; Arira Lee; Tai Kiu Choi; Borah Kim; Kang-Soo Lee; Minji Bang; Sang-Hyuk Lee Journal: Schizophr Res Date: 2018-06-09 Impact factor: 4.939
Authors: David C Glahn; J Daniel Ragland; Adir Abramoff; Jennifer Barrett; Angela R Laird; Carrie E Bearden; Dawn I Velligan Journal: Hum Brain Mapp Date: 2005-05 Impact factor: 5.038
Authors: Matthew S Panizzon; Christine Fennema-Notestine; Lisa T Eyler; Terry L Jernigan; Elizabeth Prom-Wormley; Michael Neale; Kristen Jacobson; Michael J Lyons; Michael D Grant; Carol E Franz; Hong Xian; Ming Tsuang; Bruce Fischl; Larry Seidman; Anders Dale; William S Kremen Journal: Cereb Cortex Date: 2009-03-18 Impact factor: 5.357
Authors: Dardo Tomasi; Nora D Volkow; Ruiliang Wang; Frank Telang; Gene-Jack Wang; Linda Chang; Thomas Ernst; Joanna S Fowler Journal: PLoS One Date: 2009-06-30 Impact factor: 3.240
Authors: D Tomasi; N D Volkow; G J Wang; R Wang; F Telang; E C Caparelli; C Wong; M Jayne; J S Fowler Journal: Neuroimage Date: 2010-10-26 Impact factor: 6.556
Authors: Jennifer A Hadley; Rodolphe Nenert; Nina V Kraguljac; Mark S Bolding; David M White; Frank M Skidmore; Kristina M Visscher; Adrienne C Lahti Journal: Neuropsychopharmacology Date: 2013-10-29 Impact factor: 7.853
Authors: Frederic Briend; William P Armstrong; Nina V Kraguljac; Shella D Keilhloz; Adrienne C Lahti Journal: Hum Brain Mapp Date: 2020-05-06 Impact factor: 5.399